Inventor · disambiguated record
Stephen Donald Wilton
Also filed as: WILTON STEPHEN · WILTON STEPHEN DONALD
46 granted patents·33 pending applications·2,340 citations·filing 2005–2024
99Inventor score
Files withUNIV WESTERN AUSTRALIA45WILTON STEPHEN DONALD9UNIV MONS5SAREPTA THERAPEUTICS INC4UNIV MONASH3
Top patents by PatentIndex Score
79 records- 0199US10995337B2Antisense oligonucleotides for inducing exon skipping and methods of use thereofUNIV WESTERN AUSTRALIA·Filed 2020·Granted May 4, 2021·14 cites·7 claims
- 0299US10968450B2Antisense oligonucleotides for inducing exon skipping and methods of use thereofUNIV WESTERN AUSTRALIA·Filed 2019·Granted Apr 6, 2021·14 cites·19 claims
- 0399US10781451B2Antisense oligonucleotides for inducing exon skipping and methods of use thereofUNIV WESTERN AUSTRALIA·Filed 2019·Granted Sep 22, 2020·32 cites·14 claims
- 0499USRE47751EAntisense oligonucleotides for inducing exon skipping and methods of use thereofUNIV WESTERN AUSTRALIA·Filed 2017·Granted Dec 3, 2019·41 cites·35 claims
- 0599US10421966B2Antisense oligonucleotides for inducing exon skipping and methods of use thereofUNIV WESTERN AUSTRALIA·Filed 2019·Granted Sep 24, 2019·23 cites·2 claims
- 0699US10266827B2Antisense oligonucleotides for inducing exon skipping and methods of use thereofUNIV WESTERN AUSTRALIA·Filed 2018·Granted Apr 23, 2019·33 cites·2 claims
- 0799US10227590B2Antisense oligonucleotides for inducing exon skipping and methods of use thereofUNIV WESTERN AUSTRALIA·Filed 2018·Granted Mar 12, 2019·34 cites·2 claims
- 0899US9994851B2Antisense oligonucleotides for inducing exon skipping and methods of use thereofUNIV WESTERN AUSTRALIA·Filed 2017·Granted Jun 12, 2018·51 cites·2 claims
- 0999US9605262B2Antisense oligonucleotides for inducing exon skipping and methods of use thereofUNIV WESTERN AUSTRALIA·Filed 2015·Granted Mar 28, 2017·36 cites·14 claims
- 1099US9447415B2Antisense oligonucleotides for inducing exon skipping and methods of use thereofUNIV WESTERN AUSTRALIA·Filed 2015·Granted Sep 20, 2016·99 cites·2 claims
- 1199US9441229B2Antisense oligonucleotides for inducing exon skipping and methods of use thereofUNIV WESTERN AUSTRALIA·Filed 2015·Granted Sep 13, 2016·66 cites·2 claims
- 1299US9422555B2Antisense oligonucleotides for inducing exon skipping and methods of use thereofUNIV WESTERN AUSTRALIA·Filed 2015·Granted Aug 23, 2016·68 cites·4 claims
- 1399US9249416B2Antisense oligonucleotides for inducing exon skipping and methods of use thereofUNIV WESTERN AUSTRALIA·Filed 2015·Granted Feb 2, 2016·74 cites·8 claims
- 1499US9175286B2Antisense oligonucleotides for inducing exon skipping and methods of use thereofUNIV WESTERN AUSTRALIA·Filed 2013·Granted Nov 3, 2015·74 cites·24 claims
- 1599US9035040B2Antisense oligonucleotides for inducing exon skipping and methods of use thereofUNIV WESTERN AUSTRALIA·Filed 2014·Granted May 19, 2015·67 cites·2 claims
- 1699US9024007B2Antisense oligonucleotides for inducing exon skipping and methods of use thereofUNIV WESTERN AUSTRALIA·Filed 2014·Granted May 5, 2015·90 cites·2 claims
- 1799US9018368B2Antisense oligonucleotides for inducing exon skipping and methods of use thereofUNIV WESTERN AUSTRALIA·Filed 2014·Granted Apr 28, 2015·93 cites·2 claims
- 1899US7960541B2Antisense oligonucleotides for inducing exon skipping and methods of use thereofUNIV WESTERN AUSTRALIA·Filed 2010·Granted Jun 14, 2011·147 cites·24 claims
- 1999US7807816B2Antisense oligonucleotides for inducing exon skipping and methods of use thereofUNIV WESTERN AUSTRALIA·Filed 2005·Granted Oct 5, 2010·129 cites·21 claims
- 2098USRE47769EAntisense oligonucleotides for inducing exon skipping and methods of use thereofUNIV WESTERN AUSTRALIA·Filed 2005·Granted Dec 17, 2019·31 cites·33 claims
- 2198USRE47691EAntisense oligonucleotides for inducing exon skipping and methods of use thereofUNIV WESTERN AUSTRALIA·Filed 2017·Granted Nov 5, 2019·23 cites·64 claims
- 2298US9228187B2Antisense molecules and methods for treating pathologiesUNIV WESTERN AUSTRALIA·Filed 2013·Granted Jan 5, 2016·97 cites·78 claims
- 2398US8637483B2Antisense molecules and methods for treating pathologiesWILTON STEPHEN DONALD·Filed 2010·Granted Jan 28, 2014·85 cites·46 claims
- 2498US8524880B2Antisense oligonucleotides for inducing exon skipping and methods of use thereofWILTON STEPHEN DONALD·Filed 2010·Granted Sep 3, 2013·110 cites·69 claims
- 2598US8486907B2Antisense oligonucleotides for inducing exon skipping and methods of use thereofWILTON STEPHEN DONALD·Filed 2011·Granted Jul 16, 2013·108 cites·31 claims
- 2698US8476423B2Antisense oligonucleotides for inducing exon skipping and methods of use thereofWILTON STEPHEN DONALD·Filed 2011·Granted Jul 2, 2013·75 cites·43 claims
- 2798US8455636B2Antisense oligonucleotides for inducing exon skipping and methods of use thereofWILTON STEPHEN DONALD·Filed 2011·Granted Jun 4, 2013·118 cites·43 claims
- 2898US8455634B2Antisense oligonucleotides for inducing exon skipping and methods of use thereofWILTON STEPHEN DONALD·Filed 2011·Granted Jun 4, 2013·77 cites·48 claims
- 2998US8455635B2Antisense oligonucleotides for inducing exon skipping and methods of use thereofWILTON STEPHEN DONALD·Filed 2011·Granted Jun 4, 2013·75 cites·47 claims
- 3098US8450474B2Antisense oligonucleotides for inducing exon skipping and methods of use thereofWILTON STEPHEN DONALD·Filed 2011·Granted May 28, 2013·75 cites·43 claims
- 3198US8232384B2Antisense oligonucleotides for inducing exon skipping and methods of use thereofWILTON STEPHEN DONALD·Filed 2010·Granted Jul 31, 2012·151 cites·25 claims
- 3297US10781450B2Antisense molecules and methods for treating pathologiesUNIV WESTERN AUSTRALIA·Filed 2019·Granted Sep 22, 2020·24 cites·12 claims
- 3397US9758783B2Antisense molecules and methods for treating pathologiesUNIV WESTERN AUSTRALIA·Filed 2015·Granted Sep 12, 2017·52 cites·30 claims
- 3496USRE48960EAntisense oligonucleotides for inducing exon skipping and methods of use thereofUNIV WESTERN AUSTRALIA·Filed 2019·Granted Mar 8, 2022·13 cites·76 claims
- 3595US2025163414A1Antisense oligonucleotides for inducing exon skipping and methods of use thereofUNIV WESTERN AUSTRALIA·Filed 2024·Application pending·0 cites
- 3693US10907157B2Agents useful in treating facioscapulohumeral muscular dystrophyUNIV MONS·Filed 2019·Granted Feb 2, 2021·15 cites·30 claims
- 3792US9988628B2Agents useful in treating facioscapulohumeral muscular dystrophyUNIV MONS·Filed 2016·Granted Jun 5, 2018·18 cites·2 claims
- 3885US2024401037A1Agents useful in treating facioscapulohumeral muscular dystrophyUNIV MONS·Filed 2024·Application pending·0 cites
- 3984US11441148B2Modulators and modulation of the receptor for advanced glycation end-products RNAUNIV MONASH·Filed 2021·Granted Sep 13, 2022·1 cites·27 claims
- 4082US2023063394A1Antisense molecules and methods for treating pathologiesUNIV WESTERN AUSTRALIA·Filed 2022·Application pending·0 cites
- 4181US10731156B2Restoration of the CFTR function by splicing modulationYISSUM RES DEV CO OF HEBREW UNIV JERUSALEM LTD·Filed 2018·Granted Aug 4, 2020·2 cites·20 claims
- 4280US11053494B2Methods and materials for activating an internal ribosome entry site in exon 5 of the DMD geneTHE RES INSTITUTE AT NATIONWIDE CHILDRENS HOSPITAL·Filed 2015·Granted Jul 6, 2021·2 cites·27 claims
- 4379US2021198666A1Antisense oligonucleotides for inducing exon skipping and methods of use thereofUNIV WESTERN AUSTRALIA·Filed 2020·Application pending·0 cites
- 4479US2025171783A1Antisense-induced exon2 inclusion in acid alpha-glucosidaseSAREPTA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 4577US10428328B2Restoration of the CFTR function by splicing modulationYISSUM RES DEV CO OF HEBREW UNIV JERUSALEM LTD·Filed 2015·Granted Oct 1, 2019·3 cites·9 claims
- 4676US11447776B2Antisense molecules and methods for treating pathologiesUNIV WESTERN AUSTRALIA·Filed 2020·Granted Sep 20, 2022·0 cites·36 claims
- 4774US2018163205A1Antisense oligonucleotides for inducing exon skipping and methods of use thereofUNIV WESTERN AUSTRALIA·Filed 2017·Application pending·0 cites
- 4873US11898143B2Agents useful in treating facioscapulohumeral muscular dystrophyUNIV MONS·Filed 2021·Granted Feb 13, 2024·0 cites·30 claims
- 4973US11674143B2Modulators and modulation of the receptor for advanced glycation end-products RNAUNIV MONASH·Filed 2022·Granted Jun 13, 2023·0 cites·30 claims
- 5073US2014243515A1Antisense oligonucleotides for inducing exon skipping and methods of use thereofUNIV WESTERN AUSTRALIA·Filed 2014·Application pending·0 cites
Showing the top 50 of 79 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →